Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd./ US6827361030 /
OPHLY
|
2024-05-01 9:53:37 PM
|
Chg.
+0.1300
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
4.8600USD
|
+2.75%
|
120,612
Turnover: 579,972.3011 |
-Bid Size: - |
-Ask Size: - |
10.89 bill.USD |
- |
- |
Business description
ONO Pharmaceutical Co., Ltd. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals for medical and general use.
Management board & Supervisory board
| CEO |
| Gyo Sagara |
| Management board |
| Satoshi Numata, Akira Takada, Satoshi Takahagi, Hiromu Habashita, Ph.D., Shinji Takai, M.D., Ph.D., Masaki Ito, Tatsuya Okamoto, Masayuki Tanigawa, Takehiro Yamada |
| Supervisory board |
| Toshihiro Tsujinaka, Toichi Takino, Kiyoaki Idemitsu, Masao Nomura, Akiko Okuno, Shusaku Nagae, Gyo Sagara |
Company data
| Name: |
ONO Pharmaceutical Co., Ltd. |
| Address: |
1-8-2 Kyutaro-cho, Chuo-ku,Osaka 541-8564 |
| Phone: |
+81-(0)6-6263-5670 |
| Fax: |
+81-(0)6-6263-2976 |
| E-mail: |
-
|
| Internet: |
https://www.ono-pharma.com/en |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
- |
| End of financial year: |
03-31 |
| Free Float: |
- |
| IPO date: |
1963-06-01 |
Investor relations
| Name: |
Yukio Tani |
| IR phone: |
+81-(0)6-6263-5670 |
| IR Fax: |
- |
| IR e-mail: |
-
|
Company calendar
|
CW 19 | 2024-05-09
4th Quarter/Annual Report
|
